Tokyo, Japan

Ryouta Maeba

This inventor holds 1 USPTO granted patent. Top assignees: Adeka Corporation, Hokkaido University, Teikyo University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryouta Maeba. Retrieved from https://idiyas.com/inventor/ryouta-maeba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryouta Maeba: Innovator in Metabolic Syndrome Detection

Introduction

Ryouta Maeba is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of health and medicine, particularly in the detection of metabolic syndrome and lifestyle-related diseases. His innovative approach focuses on utilizing biomarkers to enhance diagnostic accuracy.

Latest Patents

Ryouta Maeba holds 1 patent for a detection method that aims to provide a biomarker highly correlated with conventional biomarkers of metabolic syndrome. This invention is particularly beneficial for a wide range of subjects, including those aged between 40 and 74 who undergo special health check-ups. The method involves measuring the concentration of choline plasmalogen in a sample to be tested, offering an advantageous way to detect metabolic syndrome or lifestyle-related diseases.

Career Highlights

Throughout his career, Ryouta Maeba has worked with reputable organizations such as Adeka Corporation and Teikyo University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Ryouta has collaborated with notable colleagues, including Yuya Yamazaki and Megumi Nishimukai. These partnerships have contributed to his research and development efforts in the area of metabolic health.

Conclusion

Ryouta Maeba's work in the detection of metabolic syndrome represents a significant advancement in medical diagnostics. His innovative methods and collaborations highlight his commitment to improving health outcomes through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…